10-Year vaccine watch: does chikungunya shot keep working?
NCT ID NCT04838444
Summary
This study follows adults for up to 10 years after they received a single dose of an experimental chikungunya vaccine. Researchers want to see how long the vaccine's protective antibodies last and monitor participants for any long-term safety issues. The study includes about 363 people who previously participated in the vaccine's initial trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accelerated Enrollment Solutions (AES)
Phoenix, Arizona, 85020, United States
-
Accelerated Enrollment Solutions (AES)
Chicago, Illinois, 60602, United States
-
Alliance for Multispecialty Research (AMR)
Lexington, Kentucky, 40509, United States
-
Alliance for Multispecialty Research (AMR)
Knoxville, Tennessee, 37920, United States
-
Allliance for Multispecialty Research (AMR)
Norfolk, Virginia, 23502, United States
-
Velocity Clinical Research
Hallandale, Florida, 33090, United States
-
Velocity Clinical Research
Grand Island, Nebraska, 68803, United States
-
Velocity Clinical Research
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research
Austin, Texas, 78759, United States
-
Velocity Clinical Research
West Jordan, Utah, 84088, United States
Conditions
Explore the condition pages connected to this study.